Shore Capital returns AB Foods to 'buy' despite H1 disappointment
Shore Capital has returned to a 'buy' rating after a period of review, applauding the company for tacking action to improve problem areas within the business.
The broker had placed the retail and food conglomerate under review following its first-half results in late-April, in which it reported that revenues fell 2% and adjusted pre-tax profit slumped 10%.
Shore Capital highlighted some areas of "robust progress", more than offset by a number of disappointments, including within UK bread (Allied Bakeries), Spanish sugar (Azucarera) and bioethanol (Vivergo).
"Post the update, we cut FY25F pre-tax profit and adjusted EPS by 5.8% to £1.684bn and 173.5p, far from ideal, which caused us to pause and reflect on the bull case," the broker said in a research note.
"However, after a period of reflection, we see more to like than not in ABF's medium to long-term investment thesis, with high-quality assets, a very strong balance sheet, a multitude of growth opportunities and a building record of shareholder-friendly capital allocation."
Shore Capital said that AB Foods is "now more assertively dealing with current problems (on the whole).
The stock has fallen by around 9% since the interim results were announced on 29 April, but trading at a EV/EBITDA multiple of 7.2 and a price-to-earnings multiple of 12.0, falling to 5.9 and 9.6 for the fiscal year ending September 2027.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.